AstraZeneca to drop psychiatric research
AstraZeneca is to cease researching drugs for illnesses including schizophrenia and ovarian cancer in a shake-up of its research and development activities.
Psychiatry: An Industry of Death
4 days ago
No comments:
Post a Comment